HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) today announced that it is sending a letter to its shareholders updating them on certain developments regarding the Company’s Annual General Meeting of Shareholders, scheduled to take place on December 31, 2009. The full text of the letter is set forth below:
